These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20545970)

  • 1. Effectiveness, safety, and cost-effectiveness of photodynamic therapy in Barrett's esophagus: a systematic review.
    Sánchez A; Reza M; Blasco JA; Callejo D
    Dis Esophagus; 2010 Nov; 23(8):633-40. PubMed ID: 20545970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
    Vij R; Triadafilopoulos G; Owens DK; Kunz P; Sanders GD
    Gastrointest Endosc; 2004 Nov; 60(5):739-56. PubMed ID: 15557950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
    Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
    Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
    Pohl H; Sonnenberg A; Strobel S; Eckardt A; Rösch T
    Gastrointest Endosc; 2009 Oct; 70(4):623-31. PubMed ID: 19394011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?
    Inadomi JM; Saxena N
    Dig Dis Sci; 2018 Aug; 63(8):2094-2104. PubMed ID: 29948571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.
    Shaheen NJ; Inadomi JM; Overholt BF; Sharma P
    Gut; 2004 Dec; 53(12):1736-44. PubMed ID: 15542506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin.
    Fayter D; Corbett M; Heirs M; Fox D; Eastwood A
    Health Technol Assess; 2010 Jul; 14(37):1-288. PubMed ID: 20663420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
    Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
    Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D; Schmitt C; Wong JB
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations.
    Hirst NG; Gordon LG; Whiteman DC; Watson DI; Barendregt JJ
    J Gastroenterol Hepatol; 2011 Feb; 26(2):247-54. PubMed ID: 21261712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy.
    Ferguson MK; Naunheim KS
    J Thorac Cardiovasc Surg; 1997 Nov; 114(5):824-9. PubMed ID: 9375613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy.
    Menon D; Stafinski T; Wu H; Lau D; Wong C
    BMC Gastroenterol; 2010 Sep; 10():111. PubMed ID: 20875123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia.
    Hur C; Nishioka NS; Gazelle GS
    Dig Dis Sci; 2003 Jul; 48(7):1273-83. PubMed ID: 12870783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A guide for surveillance of patients with Barrett's esophagus.
    Provenzale D; Kemp JA; Arora S; Wong JB
    Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
    Gray J; Fullarton GM
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia.
    Gordon LG; Hirst NG; Mayne GC; Watson DI; Bright T; Cai W; Barbour AP; Smithers BM; Whiteman DC; Eckermann S;
    J Gastrointest Surg; 2012 Aug; 16(8):1451-61. PubMed ID: 22644445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.